HOUSTON, June 26, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, announced today it has been selected to exhibit the Aurix ® System, the first platelet rich plasma (PRP) device indicated for chronic diabetic wounds, at the Vizient Innovative... Read More

HOUSTON, June 22, 2023 (GLOBE NEWSWIRE) -- Nuo Therapeutics, Inc. (OTCQB: AURX) (“Nuo”), a commercial stage medical device company pioneering leading-edge biodynamic therapies by focusing on emerging opportunities in the evolving healthcare landscape, is pleased to announce that Wound Care Advantage (WCA) , the nation’s leading wound care consulting firm has added the Aurix ® System to its formulary. Founded in 2002, Wound... Read More